BMI View: Nigeria's pharmaceutical market will continue to be viewed as a high-risk proposition for
multinational pharmaceutical companies. Rampant corruption, coupled with widespread drug
counterfeiting and poor pharmaceutical regulations governing the market will no ..."
BMI View: Nigeria's prospects of attaining national health coverage will largely depend upon the success
of the National Health Act. This, however, will continue to face a number of challenges that have previously
led to delays in its implementation. The eventual roll ..."
BMI View: The introduction of private community microinsurance in Nigeria's Lagos state could provide a
more affordable alternative to the government-introduced coverage scheme of which uptake has been slow.
Improved health insurance coverage will help drive demand fo ..."
BMI View: Nigeria's community-based approach to its health insurance scheme will increase the
programme's penetration. We believe that this decentralisation of health services will achieve increasing
coverage among the population, driving demand for pharmaceuticals an ..."
BMI View: Nigeria's pharmaceutical and healthcare markets are vastly underdeveloped by Western
standards as poor infrastructure, a weak regulatory system and lack of specialised facilities weaken growth
potential. However, the Nigerian government's continuing efforts ..."
BMI View: The Nigerian government remains committed to improving healthcare quality and
infrastructure across the country. The formation of the National Health Insurance Scheme (NHIS) has seen
a growing number of citizens enrolled since its formation in 2005, albeit l ..."
BMI View: Nigeria's economy is largely dependent on its Oil and Gas sector. The likelihood of further
divestments by international oil companies from the sector creates a downside risk to increasing
government revenue, healthcare provision and medicines uptake over th ..."
BMI View: The Nigerian pharmaceutical industry continues to show strong growth reaffirming our positive
outlook for this quarter. An increase in urbanisation, per capita incomes and non-communicable diseases
will drive the demand of medicines along with the government ..."
BMI View: Medicines demand in Nigeria will be driven by urbanisation, rising per capita incomes, a
growing burden on non-communicable diseases and the government's plans to increase widespread
healthcare access to all citizens. However, we note that government spendin ..."
BMI View: Ensuring large low-income populations of developing countries have access to primary
healthcare services is dependent on two key factors: financial and geographical positioning. The latest
Community Based Health Insurance Scheme in Nigeria, which is based on a US$1 in ..."